Biotech · Private company · Portland, OR, US
Pdx Pharmaceuticals, Inc.
Track this companyFree. Adds Pdx Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancerFiscal year 2025 · $1.3MNIH RePORTER 5R44CA285233-03 · fetched Nov 12, 2026
- Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatmentFiscal year 2025 · $89.3KNIH RePORTER 5SB1CA287735-02 · fetched Nov 12, 2026
- Advancing the commercialization readiness of nanoparticle-based immunotherapy for cancer treatmentFiscal year 2024 · $160.7KNIH RePORTER 1SB1CA287735-01A1 · fetched Nov 12, 2026
- PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancerFiscal year 2024 · $914.2KNIH RePORTER 4R44CA285233-02 · fetched Nov 12, 2026
- Novel Nano-immunotherapy for Treatment of Non-small Cell Lung CancerFiscal year 2024 · $932.8KNIH RePORTER 5R44CA265751-03 · fetched Nov 12, 2026